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CHAPTER I.GENERAL INTRODUCTION 
Thesis Organization 
The following thesis consists of a general introduction, review of literature, materials and 
methods, results, discussion, conclusions, and acknowledgements. 
Introduction 
Lactobacilli have been evaluated for their pro biotic properties since the beginning of the 
20th century. 62 Many reports have focused on the use of lactobacilli for their beneficial, 
pro biotic effects upon the health and well being of humans and other 
animals. 27,45,47,51,53,54,64,65,71, 73,101 
The recent rise in concern over the association between the sub-therapeutic use of anti-
microbials in the swine industry -and the increased prevalence of anti-microbial resistant 
human pathogens has intensified the search for anti-microbial alternatives. Lactobacilli are 
GRAS (generally regarded as safe) organisms and are believed to have beneficial effects on 
health. Thus, lactobacilli are candidates for use as anti-microbial alternatives. 
One potential application for lactobacilli in swine is a pre-harvest method to reduce 
Salmonella. Non-typhoidal Salmonella are associated with 1.4 million cases of foodborne 
illness in the United States per year.61 Moreover, pork products are estimated to be the 
source of 6-9 percent of food borne salmonellosis in the United States. 32 
The purposes of the following studies were to 1.) evaluate feeding yogurt cultures of two 
Lactobacillus isolates as a method to reduce levels of Salmonella enterica serovar 
Typhimurium in swine and 2.) develop strains of bacteria to aid in the study of in vivo 
pro biotic mechanisms of lactobacilli. 
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CHAPTER 2. LITERATURE REVIEW 
History of Fermented Foods 
For centuries, humans have produced and consumed fermented foods. Until the late 19th 
and early 20th centuries, fruits, vegetables and milk were fermented for preservation 
purposes. Egyptians prepared and ate "leben raib", a fermented product of buffalo, cow or 
goat milk. According to the Bible (Genesis 18:8), Abraham offered several guests a 
combination of sweet and soured milk. In Russia, the long winters made necessary the 
fermentation of summer watermelons, apples, cucumbers, and other vegetables. 62 
Around the turn of the 20th century, Elie Metchnikoff made several observations that 
would change the concepts of fermented foods and microbes. One observation was the 
association between longevity and the consumption of fermented foods. In particular, 
Metchnikoff noted that there were more "old people" in Bulgaria and Eastern Europe, where 
fermented foods were part of the normal diet, than Western Europe, where fermented foods 
were consumed less frequently. In one case, Metchnikoff reported that a 180-year-old 
woman maintained her normal daily activities on a diet consisting of barley bread and sour 
milk. Metchnikoff also suggested that fermented foods were the result of lactic acid that was 
produced by microbes. 
With these observations in mind, Metchnikoff posed the following question, 
"Since the lactic fermentation is such an excellent means of preventing putrefaction in 
general, why should it not exercise this same power and prevent putrefaction in the digestive 
tube of man?" 
Metchnikoff reported the results of a few studies that demonstrated decreased levels of 
sulfur ethers in the urine of dogs and humans who had been injected with lactic acid microbe 
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or fed fermented foods, respectively. At the time, high levels of sulfur ethers were a measure 
of intestinal putrefaction. 
In essence, Metchnikoff had introduced the concept of bacteriotherapy, which eventually 
became known as probiotics. In doing so, he proposed two new ideas to microbiology. One 
concept was the use of fermented foods for purposes other than food preservation. The 
second concept was that microbes were not necessarily associated with disease, but some had 
the capacity to benefit the host. Interestingly, Metchnikoff proposed a method for 
production of fermented milk that is still used today. He suggested that milk first be 
sterilized and then inoculated with a strain of bacteria that was known to produce lactic acid. 
The efficacy of this method was proven by members of Metchnikoff s lab group who daily 
consumed the fermented milk and reported "gratifying" results. 
In 1907, Metchnikoff declared that lactic-acid producing bacteria should occupy the first 
place of honor among the microbes that are absolutely essential to our well-being. Since 
then, the beneficial effects and mechanisms of fermented foods upon humans and animals 
continue to be investigated worldwide. 62 
Definition of probiotics 
In 1965, Lilly and Stillwell first coined the term "probiotic", meaning "for life" in Greek. 
The concept that Metchnikoff introduced in the early 1900's was formally defined by Fuller 
as "probiotics" in 1989. According to Fuller, probiotics are "live microbial food 
supplements which beneficially affect the host by improving the intestinal microbial 
balance." 33 . This definition was expanded by Guarner and Schaafsma to include non-food 
preparations. They defined probiotics as "living micro-organisms, which upon ingestion in 
certain numbers, exert health affects beyond inherent basic nutrition". 40 
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Probiotic preparations containing Lactobacillus species have been developed in many 
forms. In humans, lactobacilli are most often administered in fermented milk products or as 
freeze-dried bacterial cultures. 64•92•99 Frozen, fermented milk, or freeze-dried preparations of 
bacteria have been developed for use in food production animals, such as chickens and 
swine.45•46•51 •108 Gels containing live Lactobacillus species, such as Probios™ (Pioneer 
International, Johnston, IA) and Fastrack TM (The Conklin Co. Inc., Shakopee, MN), are 
available for treatment of individual animals. 
Lactobacilli in Humans 
Although Metchnikoff first proposed the use of fermented milk for health benefits in 
humans over 100 years ago, the interest in this subject has peaked only in the past 20 years. 
Indeed, over half of the human clinical trials with pro biotic lactic acid bacteria (LAB), which 
include Lactobacillus species, that were conducted since 1961 were performed between 1991 
and 1998. 66 
In order to streamline and standardize the selection of candidate probiotics, the Lactic 
Acid Bacteria Industrial Platform (LABIP) has supported the following criteria for human 
probiotics: 
• Be of human origin 
• Demonstrate non-pathogenic behavior 
• Exhibit resistance to technological processes 
• Prove resistance to gastric acid and bile 
• Adhere to gut epithelial tissue 
• Be able to persist, albeit for short periods, in the gastrointestinal tract 
• Produce anti-microbial substances 
• Modulate immune responses 
• Have the ability to influence metabolic activities 27 
The pro biotic effects of lactobacilli have been evaluated in many different models in 
humans. Five strains of Lactobacillus, in particular, have demonstrated efficacy in humans. 
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Those strains are Lactobacfllus -aciaophilus [Cl, L. acidophilus NCFOl 748, Lactobacillus 
rhamnosus GG, Lactobacillus casei Shirota, and Lactobacillus gasseri 27 • Results have 
shown that different strains of Lactobacillus have different effects in the same model. 
Examples of these results are found in Table 1. 
Table 1. Effects of lactobacilli in humans 
Strain (Dosage) 
L. casei GG (1010-10 11 ) 
L. casei GG (10 10-10 11 ) 
L. casei GG (l 010) 
L. casei GG (l 010) 
L. acidophilus La 1 + 
Bifidobacteria Bb 12 
Model 
Rotaviral diarrhea 
" 
Rotavirus vaccine 
Salmonella Typhi 
Ty21 a vaccine 
" 
Effect 
J, duration of diarrhea 
tISC and sASC 
t IgA seroconversion 
No effect on Ab 
t serum specific IgA 
L. acidophilus Lactose intolerance No effect 
L acidophilus Lactose intolerance J, symptoms 
ISC: Immunoglobulin-secreting cells sASC: specific antibody-secreting cells 
Characterization of normal and diseased flora in humans 
Reference 
Isolauri et al. ( 1991) 
Kaila et al. ( 1992) 
Isolauri et al. ( 1995) 
Fang et al. (2000) 
Link-Amster et al. 
(1994) 
Saltzman et al. ( 1999) 
Gilliland et al. ( 1982) 
Ab: antibody 
In one study, populations of lactobacilli from 75 individuals with either healthy or 
diseased mucosa were characterized. A total of 250 isolates were tested for their ability to 
ferment 49 different carbohydrates using the API 50 CH test kit (API systems, S.A., 
Montalieu Vercieu, France). In addition, the end products from glucose were measured for 
each isolate using HPLC. Results of the in vitro tests were used to assign each Lactobacillus 
isolate to one of seventeen "clusters". Most clusters contained isolates from both diseased 
and healthy mucosa and no qualitative differences in strain composition were observed 
between different parts of the intestine. These results indicate that there is no one dominant 
species of Lactobacillus within the intestinal flora. Additionally, there was a large difference 
in the dominant Lactobacillus species between individuals. 63 
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Lactobacilli vs. gastrointestinal disorders in humans 
Results of successful treatment of gastrointestinal disorders with lactobacilli have been 
reported. Interestingly, different species of Lactobacillus have been associated with the 
treatment of different disorders. For example, results show that L. casei strain GG can be 
used for the treatment of rota viral diarrhea in children. Lactobacillus casei strain GG 
administered twice daily, at the rate of 10 10-11 colony-forming units (CFU), to patients with 
rotavirus resulted in diarrhea that lasted, on average, one day less than controls fed sterile 
milk. 43•47 Results have also shown that Lactobacillus GG is associated with successful 
treatment of recurring Clostridium difficile diarrhea. 11 Administration of Lactobacillus 
plantarum has been associated with a decrease in the symptoms associated with irritable 
bowel syndrome (IBS).69 Lactobacillus acidophilus LB has been associated with antagonistic 
activity against Helicobacter pylori infection. 17 In these models of gastrointestinal disorders 
where certain strains of Lactobacillus have been associated with successful treatment, there 
are no reports that evaluate the effects of other strains of Lactobacillus. 
Lactobacilli vs. cancer in humans 
Reports have demonstrated the use lactobacilli to treat human bladder and uterine cancer. 
Uterine cervical cancer patients treated with injected heat-killed L. casei YIT9018 and 
radiation therapy had prolonged survival and increased relapse-free intervals compared to 
radiation therapy alone. Treatment with L. casei YIT9018 also reduced the severity of 
radiation-induced leukopenia compared to untreated subjects.71 Orally administered 
Biolactis™ powder (a L. casei preparation) has been shown to decrease recurrence of 
superficial bladder cancer.7 The application for different strains of Lactobacillus to treat 
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human cancer appears to depend upon the specific form of cancer. There are no reports that 
evaluate the use of other strains of Lactobacillus to treat these forms of cancer. 
Reduction in food allergy in humans 
Infants with atopic eczema associated with food allergy were fed 5 x 108 CFU of L. 
rhamnosus GG daily in their formula for one month. Treated infants had decreased severity 
of atopic eczema compared to controls fed normal formula. Decreased intestinal 
inflammatory responses, measured by fecal TNF-a concentrations, were also observed in 
treated subjects compared to controls. 59 
Lactobacilli vs. metabolic activities in humans 
Anti-hypercholesterolemia. In one study, daily consumption of two liters of either whole 
milk or skim milk fermented with Lactobacillus bulgaricus and Streptococcus thermophilus 
was associated with a significant reduction in hypercholesterolemia using paired samples. 60 
Conversely, human subjects who daily consumed Lactinex (Becton Dickinson Microbiology 
Systems, Cockeysvile, MD) tablets containing 2 x 106 CFU of L. acidophilus and L. 
bulgaricus did not have significantly different cholesterol levels compared to controls that 
consumed placebo tablets. 54 Yogurt enriched with L. acidophilus (109-101° CFU/day) did not 
lower blood cholesterol levels in adults, compared to controls fed un-enriched yogurt. 22 
Lactose intolerance. Pasteurized whole milk containing either 2.5 x 108 CFU/ml or 2.5 x 
106 CFU/ml of L. acidophilus significantly reduced lactose malabsorption compared to 
controls fed sterile milk. In the same study pasteurized whole milk containing 2.5 x 10 7 
CFU/ml L. acidophilus did not significantly reduce lactose malabsorption. 39 Lactose 
intolerance was also reduced in children who were fed milk fermented either with L. 
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acidophilus or L. lactis and S. thermophilus. 64 Adults treated twice daily with 1 x 101° CFU 
of L. acidophilus BG2FO4 failed to reduce symptoms associated with lactose intolerance. 92 
Characterization of the ecology of lactobacilli administered orally to humans 
Characterization of the ecology of lactobacilli administered orally to humans has largely 
focused on L. rhamnosus GG and L. rhamnosus DR20. Colonoscopies and colonic biopsies 
were conducted on humans fed 6 x 101° CFU/day of L. rhamnosus GG twice daily for 12 
days. Fecal recovery of L. rhamnosus GG decreased over time. However, some subjects 
with culture-negative fecal samples maintained biopsy samples that were culture-positive. 
Two weeks after the termination of L. rhamnosus GG treatment, the administered strain was 
only recovered from biopsy samples of 2 out of 7 subjects. 3 Similar results have 
demonstrated a "diluting effect" of orally administered L. rhamnosus DR20 after termination 
of treatment. 99 
Lactobacilli in Swine 
Lactobacilli have been evaluated in swine for their probiotic effects upon weight gain and 
disease associated with Salmonella and Escherichia coli. Examples of the effects of 
Lactobacillus probiotics in swine are found in Table 2. 
Table 2. Effects of lactobacilli in swine 
Strain (Dosage) 
L. acidophilus (Probios) 
3 strains (Probios) ( 10 7) 
L. reuteri (108/ml) 
L. acidophilus RP32 (109-10 10) 
5 strains (Ferlac-2) (109) 
pCFl (109) 
( containing Lactobacillus 
species)55 
Model 
Weight gain 
Weight gain 
Coliforms 
Weight gain 
Salmonella 
Typhimurium 
challenge 
Salmonella 
Typhimurium 
challenge 
Effect 
t 
t 
-1, 
-1, Stomach and duodenum 
No effect 
t colon bacteria 
No effect on shedding or 
tissue colonization 
-1, shedding 
-1, cecal colonization 
Reference 
Pollman et al. (1980) 
Collington et al. (1988) 
Cole et al. (1987) 
Yuste et al. (1992) 
Letellier et al. (2000) 
Nisbet et al. (1999) 
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Weight gain in swine 
In 4-week-old pigs, Probios™, a commercial product containing L. acidophilus, plus 
virginiamycin increased average daily gain (ADG) and feed conversion (FC) by 9.7% and 
4.4%, respectively, compared to controls fed virginiamycin alone. 84 Similar positive effects 
of Lactobacillus fermentation products, including Probios TM, on weight gain and feed 
conversion have been reported by others 19•51 . 
Reports that do not demonstrate the efficacy of lactobacilli on weight gain in pigs also 
exist. In one study, Probios ™ did not affect the growth of grower-finisher pigs.84 Two-day-
old pigs fed 100% or 50% yogurt diets had significantly lower ADG and FC compared to 
animals fed a conventional milk diet 18• Administration of a nonviable Lactobacillus 
fermentation product (LFP) at 0.18, 0.36, or 0.72 ml/kg did not significantly effect weight 
gain in either weaned or growing-finishing pigs.41 L. acidophilus, the same species contained 
in Probios™, did not affect ADG and FC when administered to three-week-old pigs at rate of 
1 x 109 or 1 101° CFU/day. 108 These results may indicate significant differences that exist 
among different strains of Lactobacillus. Others have reported that lactobacilli do not 
significantly affect ADG and FC. 102 
Lactobacilli vs. Salmonella and E.coli in swine 
For two primary reasons, the administration of probiotics to pigs has focused on pigs four 
weeks of age or younger. One reason is the treatment or prevention of diseases such as 
Salmonella and E. coli associated with young pigs. A second reason is derived from the 
hypothesis that the most opportune time for a probiotic to colonize and establish in the 
gastrointestinal tract is during the first few days of life. 
Ferlac-2 (Rossell Institute, Montreal, Canada), consisting of L. acidophilus, L. rhamnosus, 
L. bulgaricus, Enterococcus faecium, and Streptococcus thermophilus, fed to 12-day-old pigs 
at 2 x 109 CFU/day resulted in fewer Salmonella culture-positive tissues compared to 
controls fed a diet without Ferlac-2. In the same animals, Ferlac-2 did not reduce fecal 
shedding of Salmonella. 52•53 Competitive exclusion (CE) cultures, containing Lactobacillus 
species55 , administered at rates between 5 x 109 and 5 x 1010cfu/animal have been used to 
reduce colonization and shedding of Salmonella Typhimurium in pigs two days old or 
younger, compared to untreated controls. 5•89 A fermented product consisting of L. lactis in 
combination with colostrum has been associated with increased survival and decreased 
scouring in newborn pigs challenged with E. coli 65 . 
Characterization of intestinal flora and orally administered lactobacilli in swine 
In the colon of normal pigs, L. acidophilus and L. fermentum comprise 8 .1 % and 3. 7%, 
respectively, of the total flora adherent to the colon wall. Conversely, in dysenteric pigs, 
there are no lactobacilli attached to the colonic mucosa 91 • Denaturing gradient gel 
electrophoresis (DOGE) of 16S ribosomal DNA and plasmid profiling of Lactobacillus 
isolates from nom1al pigs indicate that differences exist in the predominant Lactobacillus 
populations between individuals of the same litter. DOGE and plasmid profiling have also 
demonstrated that the predominant Lactobacillus populations change dramatically within an 
individual pig during the first two weeks of life 95•98 . The influence of weaning upon 
Lactobacillus populations attached to the ileum, pars esophagus and cecum has also been 
demonstrated by ribotyping. 50 The same study showed no difference in the predominant 
strains of Lactobacillus in pigs that were either fed a com-soy diet, a com-soy diet with 40% 
lactose, or remained with the sow during days 28 to 3 8 of age. 50 The ecology of orally 
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administered L. reuteri has been characterized. When pigs were treated with L. reuteri at a rate of 2.5 
x 101° CFU/animal, L. reuteri was recovered from fecal samples for no more than 2 days 
after treatment was terminated. 95 
Prebiotics 
Prebiotics are "non-digestible food ingredients that beneficially affect the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria in 
the colon, that can improve the host health."36 The combination of probiotics and prebiotics 
is referred to as a symbiotic. 36 Prebiotics are available in a variety of chemical compositions, 
examples of which are found in Table 3. 
Table 3. Examples of Prebiotics 
General Carbon Structure Exam le 
Disaccharides Lactulose 
Lacitol 
Polysaccharides Inulin 
Resistant Starch 
Oligosaccharides Fructo-oligosaccharides (FOS) 
Galacto-oligosaccharides 
Soybean Oligosaccharides 
Fructooligosaccharide (FOS) is the prebiotic that has been studied most extensively in 
swine. FOS delivered in drinking water increased the total number of bacteria in the colonic 
flora compared to controls with normal drinking water. 52 In a Salmonella Typhimurium 
challenge model of weaned pigs, a combination ofFerlac-2 and FOS did not reduce the 
number of tissues that were Salmonella Typhimurium culture-positive but did increase the 
total number of colonic bacteria compared to controls fed a traditional diet. 52 In one study 
FOS administered with L. paracasei to pigs improved immunostimulation compared to 
controls fed L. paracasei alone.42 
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Probiotics in Chickens 
In chickens, the administration of Lactobacillus probiotics has been evaluated for effects 
on weight gain, intestinal flora and decreased levels of Salmonella. Examples of results from 
these studies are found Table 4. 
Table 4. Efficacl of LAB in chickens 
Strain (Dosage} Model Effect Reference 
Gut contents Salmonella Infantis ,!, crop, small Nurmi et al. (1973) 
challenge intestine, cecal 
colonization 
CF (29 mixed strains) Salmonella Typhimurium ,!, cecal colonization Corrier et al. (1995) 
challenge 
Lactobacillus spp. (10 10- 10 11 ) Salmonella Infantis No effect Adler et al. ( 1980) 
challenge 
L. acidophilus (NR) Salmonella No effect Stavric et al. (1992) 
Bifidobacterium bifidum Typhimurium challenge 
L. salivarius CTC2 l 97 ( 108) Salmonella Enteritidis ,!, cecal colonization Pascual et al. ( 1999) 
challenge 
Lactobacillus spp. ( l 08) Weight gain No effect Watkins et al. (1984) 
L. acidophilus (109/gm) 1' Jin et al. (2000) 
12 strains 1' 
Lactobacillus (109/gm) 
Lactobacilli are usually administered to chickens in one of three preparations: single 
strains of Lactobacillus, multiple strains of Lactobacillus, or continuous flow cultures. 
While single and multiple strain preparations of Lactobacillus are self-explanatory, 
continuous flow cultures require some description. Typically, continuous flow cultures, also 
referred to as competitive exclusion cultures (CEC), are derived from chicken cecal contents. 
These cecal contents are used to inoculate media in a fermenter. After several days of 
growth, the fermenter reaches a "steady-state condition" at which point the bacteria are 
isolated and identified. A defined continuous flow culture is then produced from the 
bacterial isolates obtained from the steady state conditioned fermenter. All defined 
continuous flow cultures contain at least one strain of Lactobacillus. 20•68 
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Weight gain in chickens 
Lactobacillus acidophilus 26 or a mixture of 12 strains of Lactobacillus (2 strains of L. 
acidophilus, 3 strains of L. fermentum, 1 strain of L. crispatus, and 6 strains of L. brevis) 
administered in dry feed at a rate of lxl09 CFU/g significantly increased the weight of 
broilers compared to controls that did not receive any lactobacilli. 45 Others have reported 
increased body weights in broilers fed L. acidophilus compared to controls. 101 
Administration of an unidentified strain of Lactobacillus to chicks via drinking water at a 
rate of 2 x 108 CFU/chick/day did not significantly influence the weight gain in chicks 
compared to controls that were not fed Lactobacilli. 2•107 Others have reported that 
administration of Lactobacilli to chickens did not result in significant increases in weight 
gain. 106 The effect of continuous flow culture on weight gain in chickens has not been 
reported. 
Lactobacilli vs. Salmonella in chickens 
Many researchers have evaluated probiotics as a method to control Salmonella in 
chickens. While reports of the efficacy are variable, there has been a distinct progression in 
the formulation of pro biotic preparations since the early 1970' s. Nurmi and Rantala first 
described the feeding of normal adult chicken intestinal contents to reduced infection by 
Salmonella enterica subsp. enterica serovar Infantis. 70 Due to regulatory restrictions, the 
trend shifted toward defined mixtures of organisms and continuous flow cultures as 
previously described. Stavric et al. demonstrated that mixtures of several uncharacterized 
Lactobacillus isolates did not reduce levels of Salmonella Typhimurium in chicks challenged 
with 105 CFU/chick. The inclusion rate of the Lactobacillus isolates was not reported.96 
Recently, a single strain of L. salivarius was administered in feed (105 CFU/g) or water (107 
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CFU/ml) to one-day-old chicks that were subsequently challenged with Salmonella enterica 
subsp. enterica serovar Enteritidis. In both treatment groups, cecal colonization by 
Salmonella Enteritidis was reduced to 0% compared to 70% in untreated controls. 73 
Probiotics in Other Animals 
Horses 
Administration of 30 g of Probiocin (1 x 107 CFU/g of L. plantarum, L. casei, L. acidophilus, 
and S.faecium) or 15 g of Quick Fix (2.75 x 108 CFU/g of L. acidophilus, S.faecium, 
Bifidobacterium thermophilum, and B. longum) to horses following surgery for colic did not 
reduce levels of Salmonella shedding. 72 However, penicillin and gentamicin were 
administered for 2 to 3 days during probiotic treatment. There are no reports on the probiotic 
effect of lactobacilli alone in horses. 72 
Cattle 
Lactobacillus acidophilus administered orally to calves at a dose of 3 x 109 CFU in milk 
was associated with increased weight gain and feed conversion compared to controls fed 
milk without L. acidophilus. 1 However, no significant effect on weight gain was observed 
when calves were fed either a nonviable L. bulgaricus fermentation product, live L. 
acidophilus NCFM, or live L. acidophilus C-28 compared to controls fed sterile milk. 38•94 
Sheep 
Lambs treated twice with 2 ml ProbiosrM gel (1 x 107 CFU of L. plantarum, L. casei, L. 
acidophilus and Streptococcus faecalis) per treatment showed a trend towards increased 
weight gain between 2 and 6 days of age compared to control lambs treated with an inert 
placebo gel. Differences in weight between groups ranged from 4.36% to 5.67% between 2 
and 6 days of age, respectively. 6 
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Mechanisms Involved in the Beneficial Effects of Probiotics 
Several mechanisms for the beneficial effects of probiotics have been suggested, based 
upon in vitro studies. These mechanisms include decreased pH, inhibition of pathogen 
adhesion to receptor sites, production of anti-microbial compounds, and the stimulation of 
immune cells. The pro biotic mechanisms of lactobacilli have also been studied extensively 
in mouse models of immune function and human disease. Examples of the results from these 
studies are shown in Table 5. 
Table 5. Efficacy of Lactobacillus strain in mice 
Strain (Dosage) Model Effect Reference 
L. casei (109) Salmonella 
Typhimurium 
challenge 
20% survival/day dependent Perdigon et al. (1990) 
L. acidophilus ( 109) 
L. acidophilus + 
L. casei ( 109) 
20% survival 
100% survival 
L. acidophilus (I 08) No effect 
L. casei LAB-I (108) 75% survival/1' serum IgA 
L. casei LAB-2 (108) 50% survival 
L. casei Yakult ( 108) 50% survival/1' serum IgA 
L. brevis ( 108 i.p) SRBC 0TH No effect 
L. p/antarum (108 i.p.) Adjuvant effect 
Perdigon et al. ( 1991) 
Filho-Lima et al (2000) 
Paubert-Braquet et al. (1995) 
" 
Bloksma et al. (1979) 
SRBC 0TH: Sheep Red Blood Cell Delayed-Typed Hypersensitivity i.p.: intraperitoneal 
Stimulation of immune function 
Oral administration of lactobacilli has been demonstrated to increase non-specific and 
specific mechanisms of the immune system. In Salmonella challenge studies with mice, 
administration of L. casei fermented milk increased anti-Salmonella antibodies in intestinal 
fluid and in serum. In the same study, L. acidophilus reduced anti-Salmonella serum 
antibodies by 50% compared to controls that were not treated with L. acidophilus. 
Interestingly, treatment with a combination of L. casei and L. acidophilus increased serum 
anti-Salmonella antibodies 2.5-fold higher than administration of L. casei alone. 81 Similar 
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increases in serum and intestinal antibodies specific for cholera toxin 100 and trinitrophenyl 
(TNP)35 have been demonstrated in mice. In humans, oral administration of L. acidophilus 
Lal and Lactobacillus GG has increased specific IgA and immunoglobulin-secreting cells 
against Salmonella enterica subsp. enterica serovar Infantis 35 and rotavirus 47, respectively. 
Oral administration of L. acidophilus, L. bulgaricus or L. casei to mice at 109 cfu/day 
activated macrophages as measured by lysosomal activity, phagocytosis and carbon 
clearance compared to untreated controls. 77.79 Interestingly, co-administration of L. casei 
and L. acidophilus also activated macrophages in mice, although at levels lower than those 
observed with each strain alone 80. Supematants from the fermented milk cultures of these 
Lactobacillus strains also increased the number of plaque-forming cells, carbon clearance 
rates, and levels of serum antibodies in mice, compared to controls fed sterile milk. 78 In 
humans, phagocytic activity of peripheral blood leukocytes has been increased by oral 
administration of L. acidophilus Lal compared to untreated controls.24 
The addition of L. acidophilus K8, L. bulgaricus A Y, L. plantarum 14D, or L. casei 
101/37 to human peripheral blood lymphocytes resulted in the increase in interferon-y 
(IFN-y) when cells were stimulated with the mitogen, Con A. 23 Treatment of peripheral 
blood lymphocytes with heat-killed or filtered yogurt containing L. bulgaricus and S. 
thermophilus did not increase production of IFN-y as did unfiltered, live yogurt 
preparations.23 A similar study demonstrated increased production ofIL-lP, TNF-a, and 
IFN-y by human peripheral blood mononuclear cells treated with L. casei, L. acidophilus, and 
L. helveticus. Human subjects fed yogurt containing 1011 CFU of L. bulgaricus and S. 
thermophilus did not have detectable plasma levels ofIL-lP, IL-2, IFN-y, IFN-a, or TNF-a. 
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However, 2'-5' synthase activity of blood mononuclear cells was increased by 83% 
compared to milk-fed controls. 83 
In mice, intraperitoneal injection of 5 x 107, 1 x 107 or 1 x 106 CFU of L. bulgaricus 
increased serum levels ofIFN-y compared to untreated controls. This effect was augmented 
with irradiated bacteria but was abolished with heat-killed bacteria. 82 Studies with inbred 
mice demonstrate that different Lactobacillus strains stimulate different cytokine responses. 
Examples of these results are found in Table 6. 
Table 6. Crtokine ~rofiles of orallr administered Lactohacillus strains 58 
Strain ., =- > ., > tD (JQ (JQ tD = r,:i ., = C')C') r,:i '"O I I '"O :t. '"O ., :t. N "zj 0 tD I 0 •• I R ""CO I = = = tD -- Q r,:i r,:i .,tD tD 
L. murines NS NS 1' NS NS 1' 
L. casei NS NS NS NS NS 1' 
L. gasseri NS NS NS NS NS 1' 
L. plantarum 14917 NS NS NS NS NS 1' 
L. plant arum N CIB NS NS NS NS NS 1' 
L. fermentum 1' NS NS NS NS NS 
L. brevis 1' NS NS NS 1' 1' 
L. reuteri 1' 1' NS 1' 1' 1' 
1' significant (P < 0.05) increase vs. controls NS: No significant difference vs. controls 
Bacteriocins 
The first bactericidal activity oflactobacilli was described in 1961. 21 Bacteriocins 
produced by lactobacilli are typically membrane-active proteins that are less than 20 kDa, 
resistant to heat, and synthesized as precursors. 44 The activity of Lactobacillus bacteriocins 
is usually restricted to a narrow range of gram-positive organisms. Bacteriocins from many 
strains of Lactobacillus have been isolated and characterized. Lactocin 27 (12.4 kDa) and 
helveticin J (37 kDa) are produced by L. helveticus LP27. 48 Lactobacillus acidophilus N2 
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produces lactacin B, a 6.5 kDa bacteriocin. Plantaracin Bis a 8 kDa bacteriocin produced 
by L. plantarum. 48 Recently Gassericin KT7, a 5.0 kDa bacteriocin, was isolated from L. 
gasseri KT7. 109 
Interference of pathogen adh~esion to intestinal cells 
Chauviere et al. first demonstrated an inhibitory effect of live and killed L. acidophilus LB 
against adhesion of eterotoxigenic E. coli (ETEC) to the human enterocyte-like Caco-2 
cells. 13 Lactobacillus acidophilus LB and L. acidophilus LA 1 have also demonstrated, in a 
dose-dependent matter, the ability to inhibit the adhesion and invasion of enteropathogenic E. 
coli (EPEC), Salmonella Typhimurium, Listeria monocytogenes, Yersinia paratuberculosis 
with Caco-2 cells compared to untreated cells. 10 In these experiments, adhesion and 
invasion were inhibited only when either the Caco-2 cells or the pathogen were incubated 
with the Lactobacillus species prior to the adhesion/invasion assays. 15 
Antibacterial effects 
In addition, spent culture supernatant (SCS) from L. acidophilus LB alone is capable of 
decreasing the viability of Salmonella Typhimurium in Caco-2 cells, decreased F-actin 
accumulation and decreased IL-8 secretion in Caco-2 cells. Mice treated with the SCS of L. 
acidophilus LB had decreased levels of Salmonella Typhimurium per gram in feces 
compared to untreated controls. 16 Growth of Salmonella Enteritidis, enteropathogenic and 
uropathogenic E. coli and Vibrio cholera has been inhibited in co-cultures with L. paracasei 
B21060 and B21070 and L. acidophilus B21190. The role of decreased pH in these 
observations has virtually been refuted. However, coaggregation of lactobacilli with 
pathogens has been observed in co-culture. 25 Lactobacillus acidophilus and L. casei 
together, and L. casei alone, have been administered in fermented milk to reduce mortality 
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and tissue colonization in inbred mouse models of human Salmonella Typhimurium 
infection. 75•76•81 
Genetically Engineered Lactobacilli 
Recently, there has been great progress in the development of genetically engineered 
lactobacilli. The lack of characterized genetic systems and the intrinsic difficulty in working 
with Gram-positive bacteria in molecular biology techniques have provided the greatest 
hurdles in the development of recombinant lactobacilli. In spite of these difficulties, many 
researchers have developed recombinant strains of Lactobacilli for two primary objectives. 
One objective is to evaluate the dissemination and localization of specific strains of 
Lactobacillus in vitro and in vivo. The second objective for recombinant lactobacilli is the 
development of vaccine vectors. 
The development of recombinant bacteria expressing the green fluorescent protein (GFP) 
from Aequorea victoria88 has recently become an effective method for tagging specific 
strains of bacteria. GFP-expressing bacteria have been used to study host-pathogen 
interactions and bacteria in various environmental samples. 14•28•29•104 Lactobacillus 
plantarum expressing GFP have recently been developed by Geoffry et al. 34 With GFP 
under the control of the inducible nisA promoter, L. plant arum can be enumerated by flow 
cytometry. Furthermore, macrophages that have engulfed GFP-expressing L. plantarum can 
be sorted by flow cytometry from macrophages that have engulfed wild-type L. plantarum. 34 
Several properties of lactobacilli make these bacteria appealing candidates for 
recombinant vaccine vectors. Lactobacilli are "generally regarded as safe" (GRAS) 
organisms, meaning they are not considered pathogens and may be safely ingested by 
humans and other animals. In addition, many strains of Lactobacillus possess the intrinsic 
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ability to stimulate the immune system of host animals and thereby act as an adjuvant. In 
particular, the oral administration of recombinant lactobacilli would allow delivery of 
antigens directly to the mucosal surfaces of the gut, thereby stimulated local immune 
responses against specific antigens. One of the shortcomings of killed or inactivated oral 
vaccines is the lack of persistence within the intestine. If able to colonize the intestine, 
recombinant lactobacilli may provide a vehicle to circumvent this difficulty. 
Lactobacilli that either express surface bound heterologous antigens or secrete 
heterologous antigens have been evaluated for their ability to induce immune responses to 
pathogens and induce oral tolerance, respectively. Lactobacilli expressing a fusion protein of 
~-glucuronidase and an influenza HA epitope evoked a systemic antibody response to HA 
after subcutaneous priming followed by an oral booster. 86 The immunogenicity of surface 
bound tetanus toxin fragment C (TTFC) or secreting myelin basic produced by recombinant 
L. casei has been demonstrated in mice by specific antibody responses detected by ELISA 
following parenteral immunization with whole cell extracts. 57 
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CHAPTER 3. MATERIALS AND METHODS 
In Vivo Experiments 
Animals and animal care 
Three-week-old, conventional, mixed-sex pigs were purchased from either Farm A (Trettin 
Farms, Inc., Rockford, Iowa), Farm B (Prairie Gold Farms, Hancock, Minnesota), or Farm C 
(Lauren Christian Farm, Atlantic, Iowa). All animals were fed conventional diets with no 
added drugs appropriate for age and weight. A "pre-starter" diet (36.1 % com and 28.6% soy) 
was fed during the first 2-3 weeks of each trial and a "starter" diet (50.7% com and 33.4% 
soy) was fed for the duration of the study. All feed was irradiated with electron beams at a 
dose of ~7 kilogray (kGy) at the Iowa State University Linear Accelerator Facility. All 
animals were housed in confined facilities at Iowa State University. In trials 1-5, animals 
were housed on solid concrete floor. In trial 6 animals were housed on raised decks. 
Protocols for each trial were approved by the Committee on Animal Care at Iowa State 
University. All animals were acclimatized to the experimental housing conditions and diet 
for 12 days prior to the beginning of each trial. During the acclimatization period, the 
animals were determined to be Salmonella culture-negative by pen fecal samples. 
Sample collection for Salmonella isolation 
Pen fecal samples consisted of five 5-gram samples of feces were collected from the floors 
in each pen. Fecal and tonsil swabs were collected from individual animals with 
Culturette TM swabs. At necropsy, samples for qualitative Salmonella isolation were collected 
either by swabbing tissues with Culturette TM swabs or by collecting tissue samples in sterile 
Whirl pack TM stomacher bags. Approximately 3 grams were collected from each tissue 
except for cecum contents, from which 25 grams were collected. Tissue samples were 
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pulverized with a rubber mallet. For qualitative Salmonella isolation, all tissues were diluted 
1: 10 (w/v) in buffered peptone water (BPW) for pre-enrichment, homogenized by hand, and 
incubated at 37°C for 18-24 hours. After pre-enrichment, 100 µl of BPW was transferred to 
9.9 ml Rappaport-Vassiliadis (RV) broth and incubated at 42°C for 18-24 hours. After 
incubation in RV broth, a sterile cotton swab was used to transfer an aliquot of the cultures 
onto XLD agar plates. The XLD plates were streaked for isolation and incubated at 3 7°C for 
24 hours. Colonies suspected to be Salmonella were picked and transferred to Kliger' s iron 
agar, SIM semi-solid agar, phenylalanine agar, lysine iron agar, and trypticase soy agar slants 
and incubated at 3 7°C for 24 hours. Presumptive Salmonella colonies were tested for "O" 
antigens by agglutination with typing sera. Quantitative bacteriology was performed using 
the most probable number (MPN) method. All samples were pulverized with a rubber mallet 
(except for cecum contents) and diluted 1:10 (w/v) in BPW. Cecum contents were 
homogenized by hand and the remaining samples were homogenized for 60 seconds on 
normal setting in a Seward Laboratory Blender (Model 400). Homogenized samples were 
serially diluted 10-fold to 10-8. From each dilution, 1 ml was transferred to each of 5 tubes 
containing 9 ml ofBPW for pre-enrichment and incubated at 37°C for 18-24. After pre-
enrichment, 100 µl from each BPW tube was transferred to 9.9 ml RV broth and incubated at 
42°C for 18-24 hours. After incubation in RV broth, a sterile cotton swab was used to 
transfer an aliquot to XLD agar and each plate was streaked for isolation to determine if each 
tube was Salmonella culture-positive or culture-negative. Populations of Salmonella were 
determined with an MPN chart.4 
ELISA for detection of serum antibody responses 
Serum was tested using the Danish Mix-ELISA as described by Nielsen et al. 67 
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Lactobacillus cultures and yogurt preparation 
Cultures of Lactobacillus sp. strain GS-1 and Lactobacillus sp. strain GS-2 were isolated 
from the pars esophagus of a conventional pig. Stock cultures of each Lactobacillus isolate 
were maintained at -80°C in MRS broth. A high passage isolate of Lactobacillus sp. strain 
GS-1, (GS-lH), was obtained by daily sub-culturing a stock culture of Lactobacillus sp. 
strain GS-1 in MRS broth for 40 days. Yogurt starter cultures were grown overnight in 9 ml 
of MRS broth at 3 7°C and serially passaged daily during each trial by transferring ~ 100 µl to 
9 ml of fresh MRS. For each yogurt culture, 700 ml of milk (2% fat), supplemented with 2% 
(w/v) dextrose, were autoclaved for 17 minutes in 1 L Pyrex™ glass media bottles, cooled to 
room temperature and inoculated with 7 ml of overnight yogurt starter culture. Prior to each 
daily feeding, pH readings of yogurt cultures were recorded. The daily titer of Lactobacillus 
in each yogurt culture was determined by serial 10-fold dilutions in phosphate buffered saline 
(PBS, pH 7.4) and subsequent plating on MRS agar. Live yogurt cultures of Lactobacillus sp. 
strain GS-1 and GS-2 contained at least 108 CFU/ml and 107 CFU/ml, respectively. Yogurt 
cultures were killed by heating for 1 hour at 100°C or by exposure to electron beam 
irradiation at~ 7 kGy at the Iowa State University Linear Accelerator Facility. All yogurt 
cultures were fed in addition to conventional diets. 
Preparation of Salmonella inoculum 
Salmonella Typhimurium strain B was originally isolated from a sow with clinical 
salmonellosis. 8 Stock cultures of Salmonella Typhimurium strain B were grown in brain 
heart infusion (BHI) broth and maintained at -80°C. Seed cultures of Salmonella 
Typhimurium strain B were grown overnight in BHI broth at 3 7°C. The seed culture was 
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diluted 1: 100 in fresh BHI broth and incubated at 3 7°C to a final O.D.600 of 0.350, which 
corresponded to ~3 x 108 CFU/ml. The titer of the inoculum was determined by serial 10-
fold dilution in PBS, pH 7.4, and plated onto blood agar. 
Experimental designs 
Trial 1. Twenty pigs from Farm A were individually identified with a numbered ear tag 
and randomly assigned to one of 4 treatment groups (n=5). Each treatment group was 
assigned to a separate room. The GS-1 group was fed yogurt fermented with Lactobacillus 
sp. strain GS-1. The GS-2 group was fed yogurt fermented with Lactobacillus sp. strain 
GS-2. The sterile milk group was fed un-inoculated, sterile milk. The strict control group 
received no treatment. All groups were fed the appropriate yogurt cultures on a daily basis 
for 8 days prior to and 26 days after inoculation with Salmonella Typhimurium strain B. On 
day 27, samples of inocula for the GS-1 and GS-2 yogurt cultures were frozen at -80°C and 
were identified as Lactobacillus sp. strain L T-60 and Lactobacillus sp. strain L T-61, 
respectively. On day 0, animals were inoculated intranasally with 3 x 108 CFU of 
Salmonella Typhimurium strain B via a 1.5 inch Teflon catheter. Fecal samples were 
collected on days -12, 2, 4, 7, 9, 11, 14, 17, 19, 21 and 24. Palatine tonsil swabs were 
collected on days 15 and 21. Blood was collected on days -1, 4, 14, 21 and 27. The study 
was terminated on day 27 and qualitative Salmonella isolation was performed using 
Culturette TM swabs from tonsil, mandibular lymph node, liver, spleen, ileocecal lymph node, 
jejunal lymph node, ileum contents, and colon contents. Tonsil and ileocecal lymph node 
were also collected for quantitative Salmonella isolation. 
Trial 2. Twenty-five pigs from Farm A were individually identified with a numbered ear 
tag and randomly assigned to one of three treatment groups. Each treatment group was 
25 
assigned to a separate room. The GS-I group (n=I0) and GS-I/unchallenged groups (n=5) 
were fed yogurt fermented with Lactobacillus sp. strain GS-I. The sterile milk group (n=I0) 
was fed un-inoculated, sterile milk. All groups were fed the appropriate yogurt cultures on a 
daily basis for 8 days prior to and 26 days after inoculation with Salmonella Typhimurium 
strain B. On day 27, a sample of the inoculum for the GS-I yogurt cultures was frozen at-
800C and was identified as Lactobacillus sp. strain L T-62. On day 0, animals in the GS- I 
and sterile milk group were inoculated intranasally with 108 CFU of Salmonella 
Typhimurium strain B via a 1.5 inch Teflon catheter. Fecal samples were collected on days 
-1, 2, 4, 7, 9, 11 , 14, 17, 19, 21, 23, 25, and 27. Tonsil samples were collected on days-I, 2, 
5, 7, 9, 11, 15, 21, 23, and 27. Blood was collected on days -1, 7, 14, 21, and 27. Three and 
two animals from the GS-1 and sterile milk group were randomly euthanized and necropsied 
on day 2 and day 9, respectively. The study was terminated on day 27. At each necropsy 
samples for qualitative Salmonella isolation were colleced using Culturette TM swabs of tonsil, 
mandibular lymph node, liver, spleen, ileocecal lymph node, jejunal lymph node, ileum 
contents, and colon contents. Tonsil, ileocecal lymph node, and cecum contents were also 
collected for quantitative Salmonella isolation. 
Trial 3. Twenty-five pigs from Farm A were individually identified with a numbered ear 
tag and randomly assigned to one of 5 treatment groups (n=5). Each treatment group was 
assigned to a separate room. The GS-1 group was fed yogurt fermented with Lactobacillus 
sp. strain GS-1. The IRR group was fed an irradiated preparation of yogurt fermented with 
Lactobacillus sp. strain GS-1 . The HK group was fed a heat-killed preparation of yogurt 
fermented with Lactobacillus sp. strain GS-1. The sterile milk group was fed un-inoculated, 
sterile milk. The strict control group was not treated. All groups were fed the appropriate 
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yogurt cultures on a daily basis for 8 days prior to and 26 days after inoculation with 
Salmonella Typhimurium strain B. Animals in the GS-1, IRR, HK, and sterile milk groups 
were inoculated with Salmonella Typhimurium strain Bas in previous trials. Fecal, tonsil 
and blood samples were collected on the same days as in trial 2. The study was terminated 
on day 27. Tissues were collected from the strict control, sterile milk, and IRR groups. 
Qualitative Salmonella isolation was performed on~ 3-gram samples of tonsil, mandibular 
lymph node, liver, spleen, ileocecal lymph node, jejuna! lymph node, and ileum contents and 
~ 25-gram samples of cecum contents. Tonsil and cecum contents were also collected for 
quantitative Salmonella isolation. 
Trial 4. Twenty-five pigs from Farm A were individually identified with a numbered ear 
tag randomly assigned to one of five treatment groups (n=5). Each treatment group was 
assigned to a separate room. The GS-1 H group was fed yogurt fermented Lactobacillus sp. 
strain GS-1 H. The GS-1 group was fed yogurt fermented with Lactobacillus sp. strain GS-1. 
The GS-2 group was fed yogurt fermented with Lactobacillus sp. strain GS-2. The sterile 
milk group was fed un-inoculated, sterile milk. The strict control group was not treated. All 
groups were fed the appropriate yogurt cultures on a daily basis for 8 days prior to and 26 
days after inoculation with Salmonella Typhimurium strain B. Animals in the GS-1 H, GS-1, 
GS-2, and sterile milk groups were inoculated with Salmonella Typhimurium strain B as in 
previous trials. Fecal, tonsil and blood samples were collected on the same days as in trial 2. 
The study was terminated on day 27. Tissues were collected from the sterile milk and GS-2. 
Qualitative Salmonella isolation was performed on~ 3-gram samples of tonsil, mandibular 
lymph node, liver, spleen, ileocecal lymph node, jejuna! lymph node, and ileum contents and 
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~ 25-gram samples of cecum contents. Tonsil and cecum contents were also collected for 
quantitative Salmonella isolation. 
Trial 5. Twenty-five pigs from Farm B were individually identified with a numbered ear 
tag and randomly assigned to one of five treatment groups (n=5). Each treatment group was 
assigned to a separate room. The GS-1 group was fed yogurt fermented with Lactobacillus 
sp. strain GS-1. The GS-1 + FOS group was fed yogurt fermented with Lactobacillus sp. 
strain GS-1 containing 5 grams of fructooligosaccharide (FOS). The GS-2 group was fed 
yogurt fermented with Lactobacillus sp. strain GS-2. The sterile milk group was fed un-
inoculated, sterile milk. The strict control group was not treated. All groups were fed the 
appropriate yogurt cultures on a daily basis for 8 days prior to and 18 days after inoculation 
with Salmonella Typhimurium strain B. Animals in the GS-1, GS-1 + FOS, GS-2, and sterile 
milk groups were inoculated with Salmonella Typhimurium strain B as in previous trials. 
Fecal, tonsil and blood samples were collected on the same days as in trial 2. The study was 
terminated on day 27. Tissues were collected from all treatment groups. Qualitative 
Salmonella isolation was performed on~ 3-gram samples of tonsil, mandibular lymph node, 
liver, spleen, ileocecal lymph node, jejunal lymph node, and ileum contents and~ 25-gram 
samples of cecum contents. Tonsil and cecum contents were also collected for quantitative 
Salmonella isolation 
Trial 6. Twelve pigs from Farm C were individually identified with a numbered ear tag 
and randomly assigned to one of three treatment groups (n=4). Each treatment group was 
assigned to a separate room. The GS-1 group was daily fed 1.4 liters of yogurt culture 
fermented with Lactobacillus sp. strain GS-1. The sterile milk group was fed 1.4 liters of un-
inoculated, sterile milk per day. The strict control group was not treated. All groups were 
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fed the appropriate yogurt cultures for 8 days prior to and 13 days after inoculation with 
Salmonella Typhimurium strain B. On day 0, animals were inoculated intranasally with 3 x 
106 CFU of Salmonella Typhimurium strain B via a 1.5 inch Teflon catheter. Fecal and 
tonsil samples were collected on days -12, 2, 4, 7, 9, 11, and 14. Blood was collected on 
days -10, 7, and 14. The study was terminated on day 14. Tissues were collected from all 
treatment groups. Quantitative and qualitative Salmonella isolation were performed as in 
trial 5. Approximately 3 grams of colon contents were also collected for qualitative 
Salmonella isolation. 
In Vitro Experiments 
Strain identification 
The ability of Lactobacillus sp. strain GS-1 and Lactobacillus sp. strain GS-2 to ferment 
49 different carbohydrates was tested using the API 50 CH test kit (API systems, S.A., 
Montalieu Vercieu, France) according to the manufacturers' instructions. Inocula were 
prepared in MRS broth incubated overnight at 37°C. Tests were read after incubation at 37°C 
for 2 days and 7 days. Results were rated from O (violet) to 5 (yellow), and 3-5 were scored 
positive. 
Antibiotic resistant Lactobacillus mutants 
Antibiotic resistant strains of Lactobacillus sp. strain GS-1 and GS-2 were developed 
using a gradient plating method. Initially, each strain was streaked on MRS agar containing a 
rifampin gradient of 0-10 µg/ml. Plates were incubated anaerobically overnight at 3 7°C. 
Resistant colonies were re-streaked on gradient plates containing increasing amounts of 
rifampin until colonies resistant to 30 µg/ml were obtained. Rifampin resistant isolates were 
subsequently cultured in a similar manner on MRS agar containing 30 µg/ml of rifampin and 
29 
increasing concentrations of streptomycin until isolates resistant to 30 µg/ml of rifampin and 
400 µg/ml streptomycin were obtained. 
Salmonella Typhimurium x4232 expressing GFP 
Plasmids and bacterial strains. Salmonella Typhimurium x4232 (NalR) (courtesy of Dr. 
Scott Hurd, NADC, Ames, Iowa) was used as the recipient. E. coli DH5a harboring the 
pVLacGreen plasmid (courtesy of Dr. Gwyn Beattie, Iowa State University), was used as the 
donor. p VLacGreen contains green fluorescent protein (GFP) under the control of the Lac 
promoter, a kanamycin resistance gene, and has a broad host range origin of replication. E. 
coli DH5a harboring the pRK.2073 plasmid (courtesy of Dr. Gwyn Beattie, Iowa State 
University) was used as the helper strain. The plasmid pRK.2073 encodes streptomycin and 
spectinomycin resistance genes. 
Tri-parental mating. The donor, helper, and recipient were each grown overnight at 37°C 
with 225 r.p.m. rotary shaking. One hundred microliterss of each overnight culture was 
added to one microcentrifuge tube (mating mix) and inverted gently to mix. Ten microliters 
from the donor, helper, recipient, and mating mix were spotted onto Lauria-Bertanelli (LB) 
agar without antibiotics and the plate was incubated overnight at 37°C. The next day, each 
sample was streaked for isolation onto LB agar containing the appropriate antibiotic. 
Individual plates were examined under ultraviolet light to detect the expression of GFP. The 
exconjugate was identified as Salmonella Typhimurium x4232/GFP. 
Phagocytosis assay 
Salmonella Typhimurium x4232/GFP was grown overnight in LB broth at 37°C. Two 
milliliters of the overnight culture were centrifuged at 5000 x g for 15 minutes and 
resuspended in 100 µl PBS, pH 7.4. Twenty microliters of the PBS suspension were added 
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to each of two tubes (control and experimental) containing 100µ1 of fresh, heparinized blood 
from a conventional pig. As a positive control for the assay, 1 0µl of FITC-conjugated E. coli 
(courtesy of Dr. Joan Cunnick, Iowa State University) were added to each of two tubes 
( control and experimental) containing 100 µl of fresh, heparinized blood from a conventional 
pig. Control and experimental tubes were incubated for 10 minutes on ice and at 3 7°C, 
respectively. All tubes were then placed in a 0°C water bath and 100 µl ice-cold quenching 
solution (3 mg/ml trypan blue in PBS, pH 7.4) were added to each tube. Each tube was 
briefly vortexed and 2 ml of ice-cold washing solution (1.0% paraformaldehyde in PBS, pH 
7.4)) was added to each tube. All tubes were centrifuged at 250 x g for 5 minutes at 4°C and 
the supernatant was discarded. Two milliliters of lysing solution (0.15 M ammonium 
chloride, 10 mM sodium bicarbonate, 0.1 mM EDT A disodium) were added to each tube and 
the tubes were incubated at room temperature for 15 minutes. The tubes were centrifuged at 
250 x g for 5 minutes at 4°C. Pellets were washed with 2 ml of wash solution, centrifuged at 
250 x g, and decanted. One hundred microliters of propidium iodide (50 µg/ml in PBS, pH 
7.4) were added to each pellet. Each tube was vortexed briefly and incubated in the dark at 
0°C for 10 minutes. Wet mount slides were prepared and observed with epiflourescence 
microscopy. 
Lactobacillus mini-preps 
Lac to bacillus spp. strains GS-1, GS-1 H, GS-2, and L T-60 were each grown overnight at 
37°C in 500 ml MRS broth and centrifuged for 20 minutes at 5000 x g. The cells were 
washed twice in 25 ml of20 mM Tris-HCl (pH 8.0). Cells were resuspended in 20 ml of20 
mM Tris-HCl (pH 8.0) containing 5 mg/ml hen egg white lysozyme and 20 ml of 24% 
polyethylene glycol 8000 and incubated for 2 hours at 37°C. Cells were centrifuged for 20 
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minutes at 5000 x g and washed in 20 mM Tris-HCl (pH 8.0). Cells were resuspended in the 
cell suspension buffer of the Promega Maxi-Prep™ kit. Plasmids were isolated according to 
the manufacturer's protocol and resuspended in 100 µl ofTris-EDTA (pH 7.4). 
Spot test assay 
Lactobacillus spp. strains GS-1, GS-lH, GS-2, LT-60, and LT-61 were grown overnight in 
MRS broth at 3 7°C. Five micro liters from each overnight culture were spotted onto MRS 
agar plates. As a control, 5 µl of MRS broth samples, adjusted for the pH after overnight 
growth (pH 3.8 and 4.2 for GS-1 and GS-2, respectively) were spotted onto MRS agar plates. 
Each plate was incubated anaerobically at 3 7°C for 18 hours. Five milliliters of BHI top agar 
(0.75% agar) containing 107 CFU of Salmonella Typhimurium strain B were poured onto the 
MRS plates and the plates were incubated aerobically at 3 7°C. Inhibitory activity of 
Lactobacilli was observed after overnight incubation. 
Agar well diffusion assay 
Lactobacillus sp. strain GS-1 and Lactobacillus sp. strain GS-2 were grown overnight in 
MRS broth at 3 7°C. Overnight cultures were centrifuged at 5000 x g for 15 minutes and the 
spent culture supernatant (SCS) was collected. Fifty microliters of SCS from Lactobacillus 
sp. strain GS-1 and Lactobacillus sp. strain GS-2 were added to 4 mm diameter wells in MRS 
agar. As a control, MRS broth samples, adjusted for the pH after overnight growth (pH 3.8 
and 4.2 for GS-1 and GS-2, respectively) were each added to a well. The plates were 
incubated at room temperature until each sample was absorbed by the agar. Then, 5 ml of 
BHI top agar (0.75% agar) containing 107 CFU of Salmonella Typhimurium strain B were 
poured onto the MRS plates and the plates were incubated aerobically at 37°C. Inhibitory 
activity of each Lactobacillus strain was observed after overnight incubation. 
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CHAPTER4.RESULTS 
In Vivo Experiments 
Trial 1 
Serum antibody levels. On day -1, anti-Salmonella serum antibodies were not detected 
in any animal. The group mean antibody levels are shown in Figure 1. After inoculation with 
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Figure 1. Trial 1 anti-Salmonella serum antibody levels 
Salmonella Typhimurium strain B, the mean anti-Salmonella serum antibody levels in all 
groups increased through day 14. While there was a trend towards higher anti-Salmonella 
serum antibody levels in the sterile milk group compared to the GS-1 and GS-2 groups, there 
was no statistically significant (P > 0.05) difference between any groups on any day after 
challenge. 
Salmonella isolation from fecal samples. Fecal samples collected from all animals on 
day -12 were Salmonella culture-negative (Figure 2). On day -1, pen fecal samples collected 
from all groups were Salmonella culture-negative. The strict control group remained 
Salmonella culture-negative throughout the study. On day 2, there were fewer Salmonella 
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Figure 2. Trial 1 Salmonella culture-positive fecal samples 
culture-positive animals in the GS-1 (40%) and GS-2 (60%) groups compared to the sterile 
milk group ( 100% ). This trend continued throughout the duration of the study. On days 9 
and 11 there were significantly (P < 0.05) fewer Salmonella culture-positive fecal samples 
collected from GS-1 compared to sterile milk. After day 11, Salmonella was never recovered 
from any fecal sample collected from the GS-1 group. Salmonella was recovered from fecal 
samples of at least one animal from the GS-2 and sterile milk groups throughout the study. 
Salmonella isolation from tonsil samples. On days 15 and 21, the sterile milk group 
(100%) had significantly (P > 0.05) more Salmonella culture-positive tonsil samples than the 
GS-1 (0%) group (Figure 3). Although there were fewer Salmonella culture-positive tonsil 
samples in the GS-2 group (40%) compared to the sterile milk group on days 15 and 21, the 
difference was not statistically significant (P > 0.05) on either day. 
Quantitative Salmonella isolation from tissues. On day 27, results of quantitative 
I 
bacteriology of Salmonella from the tonsils of the GS-2 group and the ileocecal lymph nodes 
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Figure 3. Trial 1 Salmonella culture-positive tonsil samples 
from all groups were not obtained due to technical error. There was a non-significant (P > 
0.05) trend towards fewer Salmonella CFU per gram of tonsil in the GS-1 (2.0 x 103 ± 3.4 x 
103) compared to the sterile milk group (1.4 x 104 ± 1.2 x 104). 
Trial 2 
Serum antibody levels. On day -1, anti-Salmonella serum antibodies were not detected 
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Figure 4. Trial 2 anti-Salmonella serum antibody levels 
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in any animal. The group mean anti-Salmonella serum antibody levels are shown in Figure 
4.The GS-lino challenge group remained sero-negative throughout the study while serum 
antibody levels in the GS-1 and sterile milk group increased through days 14 and 21, 
respectively. The mean serum antibody levels did not differ significantly (P > 0.05) between 
the GS-1 and sterile milk groups on any day. 
Salmonella isolation from fecal samples. Fecal samples collected from all animals on 
day -12 were Salmonella culture-negative (Figure 5). On day -1, pen fecal samples collected 
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Figure 5. Trial 2 Salmonella culture-positive fecal samples 
from all groups were Salmonella culture-negative. All animals in the GS-1/unchallenged 
group remained Salmonella culture-negative throughout the study. On day 2, there were 
fewer Salmonella culture-positive animals in the GS-1 (43%) group compared to the sterile 
milk group (100%). This trend continued throughout the duration of the study. After day 11 
there were no Salmonella culture-positive fecal samples collected from the GS-1 group while 
Salmonella culture-positive fecal samples were collected from the sterile milk group through 
day 27. 
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Figure 6. Trial 2 Salmonella culture-positive tonsil samples 
Salmonella isolation from tonsil samples. On day -1, tonsil samples collected from all 
animals were Salmonella culture-negative (Figure 6). All animals in the GS-1/unchallenged 
group remained Salmonella culture-negative throughout the study. On day 2, there were 
fewer Salmonella culture-positive tonsil samples were collected from animals in the GS-1 
( 60%) compared to the sterile milk group (80% ). This trend continued throughout the 
duration of the study. On day 11, the difference between the GS-1 (20%) and sterile milk 
group (80%) was statistically significant (P < 0.05). There were no Salmonella culture-
positive tonsil samples collected from the GS-1 group after day 9 while culture-positive 
samples were collected from the sterile milk group through day 23. 
Quantitative Salmonella isolation from tissues. On day 2, there was non-significant 
(P > 0.05) trend towards reduced mean Salmonella CFU per gram in the tonsils (19.0 ± 26.4 
vs. 2.3 x 104 ± 4.0 x 104) , ileocecal lymph nodes (1.36 ± 2.4 vs. 22 ± 19.1), and cecum 
contents (1.8 ± 2.4 vs. 1.6 x 104 ± 2.8 x 104) of the GS-1 group vs. sterile milk group, 
respectively. On day 9 a similar, non-significant (P > 0.05), trend towards decreased 
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Salmonella populations was observed in tonsil, ileocecal lymph node and cecum for the GS-1 
group compared to the sterile milk group. On day 27, there was a non-significant (P > 0.05) 
trend towards reduced mean Salmonella CFU per gram in the tonsils of the GS-1 group (9.8 
x 103 ± 2.2 x 104) compared to sterile milk group (1.4 x 104 ± 1.2 x 104). The mean 
Salmonella CFU per gram of cecum contents on day 27 was significantly (P < 0.05) lower in 
the GS-1 group (17 ± 35) compared to the sterile milk group (304 ± 338) (Figure 7). 
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Figure 7. Trial 2 Salmonella populations in cecum contents on day 27 
Cumulative results from trials 1 and 2 
Salmonella isolation from fecal and tonsil samples. Results from trials 1 and 2 were 
pooled (Table 7). There was a significant (P > 0.05) difference in the mean number of days 
during which Salmonella was recovered from individual fecal samples in the GS-1 group (3 .3 
± 1.96) compared to the sterile milk group (17.5 ± 1.96). There was a significant (P > 0.05) 
difference in the mean number of days during which Salmonella was recovered from 
individual tonsil samples in the GS-1 group ( 4. 0 ± 1. 4) compared to the sterile milk group 
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Table 7. Summary of Salmonella culture-positive fecal and tonsil samples from trials 1 
and2 
Treatment Group Parameter Number of Animals Mean Number of 
culture-positive days (S.E.) 
GS-I Feces 10 3.3 (1.96)3 
GS-2 5 12.0 (2.8) 
Sterile Milk 10 17.5 (I.96t 
GS-I Tonsil 5 4.0 (1.4)3 
Sterile Milk 5 21 (I .St 
a,b Different letters indicate P<0.05 for difference between means with a parameter 
(21 ± 1.5). There was a non-significant (P > 0.05) difference in the mean number of days 
during which Salmonella was recovered from individual fecal samples in the GS-2 (12.0 ± 
2.8) compared to the sterile milk group. 
Salmonella isolation from tissues. The qualitative Salmonella culture results from 
necropsy on day 27 of trials 1 and 2 were pooled (Table 8). The mandibular lymph node, 
Table 8. Isolation of Salmonella from tissues of pigs in trials 1 and 2 
Sam pie Sterile Milk GS-1 
Tonsil* 
Mandibular Lymph Node 
Liver 
Spleen 
Jejunal Lymph Node 
Ileocecal Lymph Node 
Ileum Contents 
Cecum Contents 
Total* 
(positive/total) (positive/total) 
7/10 2/10 
0/10 0/10 
0/10 0/10 
0/10 0/10 
0/10 0/10 
3/10 1/10 
2/10 1/10 
4/10 2/10 
16/80 (20%) 6/80 (7.5%) 
* P<0.05 for difference in proportions within rows 
liver, spleen, and jejunal lymph node in all animals were Salmonella culture-negative. 
Salmonella was recovered from the tonsil, ileocecal lymph node, ileum contents and cecum 
contents from the GS-1 group and sterile milk groups. In all culture-positive tissues, there 
was a trend towards decreased numbers of culture-positive tissues in the GS-1 group 
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compared to the sterile milk group. There were significantly fewer culture-positive tonsils in 
the GS-1 group (2/10) compared to the sterile milk group (7 /10). Salmonella was recovered 
from a significantly (P < 0.05) greater proportion of tissues in the sterile milk group (20%) 
than the GS-I group (7.5%). 
Trial 3 
Salmonella isolation. On day -12, fecal samples collected from all animals were 
Salmonella culture negative (Figure 8). All animals in the strict control group remained 
100% 
90% f------ - -
80% ~- - -
Q) 70% ~- - -
60% ·w 
0 
f------ - - I- Sterile Milk 
Q. 50% c -- - - DGS-1 1, 
Q) 
40% 
Q) 
Q. 30% 
f------ - I\ - I- I- I- I- Irradiated 
,, 
IIIIHeat Killed ;: 
f------ - I- I- I- I- I- 1-- I-
20% - - - I- I- ,, I- I- I- I- I-
10% -- - ,- 1, 1, 
0% ! 
; 1 
-12 2 4 7 9 11 14 18 21 25 
Days Post-challenge 
Figure 8. Trial 3 Salmonella culture-positive fecal samples 
Salmonella culture-negative throughout the study. Salmonella culture-positive fecal samples 
were collected from all animals in the GS-1, HK, and sterile milk groups on day 2 after 
inoculation (Figure 8). At least one animal in the sterile milk group had a culture-positive 
fecal sample on each day of sampling. There was no significant (P > 0.05) difference in the 
number of culture-positive samples collect from any treatment group compared to the sterile 
milk group on any day. A similar, non-significant trend was observed in Salmonella 
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Table 9. Trial 3 Salmonella isolation from tissues 
Sample 
Tonsil 
Mandibular Lymph Node 
Liver 
Spleen 
Jejuna} Lymph Node 
Ileocecal Lymph Node 
Ileum Contents 
Cecum Contents 
Total 
Sterile Milk 
(positive/total) 
4/4 
1/4 
1/4 
1/4 
1/4 
2/4 
3/4 
2/4 
15/32 (47%) 
Irradiated GS-1 
(positive/total) 
1/5 
1/5 
5/5 
0/5 
0/5 
0/5 
1/5 
0/5 
8/40 (20%) 
isolation from tonsil samples. On day 14, one animal from the sterile milk group while blood 
was being collected. At the end of the trial, there was no significant (P > 0.05) difference in 
Salmonella from the tonsil, mandibular lymph node, lung, liver, spleen, ileum contents, 
cecum contents, jejunal lymph node, or ileocecal lymph node (Table 9.) 
Trial 4 
Salmonella isolation. All animals were Salmonella culture-negative prior to inoculation 
with Salmonella Typhimurium strain B (Figure 9). The strict control group remained 
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Figure 9. Trial 4 Salmonella culture-positive tonsil samples 
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Salmonella culture-negative throughout the study. On day 2, Salmonella culture-positive 
fecal samples were collected from all the animals in GS- I and sterile milk groups. At least 
one animal in the sterile milk group had a culture-positive fecal sample on each day of 
sampling. There was no significant (P > 0.05) difference in the number of culture-positive 
samples collected from any treatment group compared to the sterile milk group on any day. 
A similar, non-significant trend was observed in Salmonella isolation from tonsil samples. 
On day 6, one animal in the GS- I group died. Results of a post-mortem examination 
indicated that the animal probably died from salmonellosis. On day 18, one animal in the 
GS-I group was euthanized due to lameness. At the end of the trial, no significant (P > 0.05) 
difference was detected from qualitative or quantitative bacteriology of tonsil, mandibular 
lymph node, lung, liver, spleen, 
Table 10. Trial 4 Salmonella isolation from tissues 
Sample Sterile Milk GS-2 
Tonsil 
Mandibular Lymph Node 
Lung 
Liver 
Spleen 
Jejuna! Lymph Node 
Ileocecal Lymph Node 
Ileum Contents 
Cecum Contents 
Total 
(positive/total) (positive/total) 
5/5 5/5 
3/5 5/5 
1/5 1/5 
1/5 1/5 
0/5 0/5 
3/5 2/5 
2/5 3/5 
4/5 5/5 
5/5 4/5 
25/46 (56%) 28/45 (62%) 
ileum contents, cecum contents, jejunal lymph node, or ileocecal lymph node (Table 10). 
Feed Analysis. Oxytetracycline was detected at ~25 ppm in the starter feed but not pre-
starter feed from trial 4 (Table 11 ). No detectable amounts of chlortetracycline, penicillin G 
and sulfamethazine were detected in either the pre-starter or starter feeds in trial 4. 
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Table 11. Antibiotic analysis of feed from trial 4 
Antibiotic Pre-Starter 
Oxytetracycline No detectable amount 
Chlortetracylcline No detectable amount 
Penicillin G No detectable amount 
Sulfamethazine No detectable amount 
Trial 5 
Starter 
~25 ppm 
No detectable amount 
No detectable amount 
No detectable amount 
Salmonella isolation. All animals were Salmonella culture-negative prior to inoculation 
with Salmonella Typhimurium strain B. Animals in the strict control group remained 
Salmonella culture-negative throughout the study. On days 2 and 4 Salmonella culture-
positive fecal samples were collected from all animals in all groups (Figure 10). Salmonella 
culture-positive fecal samples were collected from at least 3 animals each day after 
inoculation. There was no significant (P > 0.05) difference in the number of culture-positive 
samples collected from any treatment group compared to the sterile milk group on any day. A 
similar, non-significant trend was observed in Salmonella isolation from tonsil samples. At 
100% - - -
90% - - -
80% - - f- -
Q.) 70% - - - - - - -
> 
·en 60% 
0 a.. 
50% c 
- - f- f- f- - -
,; 
Milk 
- - - - - - - DGS-1 
40% - - - - - - -
Q.) 
a.. 30% 
+ FOS 
- - f- f- f- - - eGS-2 
20% --- - - - - - -
10% 
11 
- I- f- - -
0% --,-- '-,-- --,-- --,-- "'- --,--
-12 2 4 7 11 14 17 19 
Day (Challenge= 0) 
Figure 10. Trial 5 Salmonella culture-positive fecal samples 
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Table 12. Trial 5 Salmonella isolation from tissues 
Sample Sterile Milk GS-1 GS-1 + FOS GS-2 
(eositive/total) (eositive/total) (eositive/total) (eositive/total) 
Tonsil 5/5 3/3 5/5 4/5 
Mandibular Lymph Node 2/5 2/3 2/5 3/5 
Lung 1/5 0/3 2/5 0/5 
Liver 0/5 2/3 3/5 0/5 
Spleen 0/5 1/3 3/5 0/5 
Jejunal Lymph Node 1/5 1/3 1/5 2/5 
Ileocecal Lymph Node 4/5 1/3 2/5 4/5 
Ileum Contents 3/5 1/3 2/5 2/5 
Cecum Contents 4/5 3/3 4/5 5/5 
Total 20/45 (44%) 14/27 (52%) 24/45 (53%~ 20/45 (44%) 
the end of the trial, no significant (P > 0.05) difference was detected from qualitative or 
quantitative bacteriology of tonsil, mandibular lymph node, lung, liver, spleen, ileum 
contents, cecum contents, jejunal lymph node, or ileocecal lymph node (Table 12). 
Feed analysis. No detectable amounts of oxytetracycline, chlortetracycline, penicillin G 
or sulfamethazine were in either the pre-starter or starter feeds in Trial 5. 
Trial 6 
Salmonella isolation from fecal samples. All animals were Salmonella culture-negative 
prior to inoculation with Salmonella Typhimurium strain B. Animals in the strict control 
group remained Salmonella culture-negative throughout the study. On day 2 there were 
fewer Salmonella culture-positive samples in the GS-1 group (50%) than the sterile milk 
group ( 100%) (Figure 11 ). This trend did not continue through the study. On day 14, there 
were more Salmonella culture-positive samples in the GS-1 group (100%) than the sterile 
milk group (25% ). 
Salmonella isolation from tonsil samples. On day 2, there were no Salmonella culture-
positive tonsil samples collected from any animal (Figure 12). On day 4, there was a higher 
but non-significant (P >0.05) number of Salmonella culture-positive tonsil samples in the 
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Figure 11. Trial 6 Salmonella culture-positive fecal samples 
sterile milk group ( I 00%) compared to the GS- I group (25% ). After day 9, Salmonella was 
never recovered from any tonsil sample collected from the GS- I group. Salmonella was 
recovered from tonsil samples in the sterile milk group through the study. There was a 
significant difference in the mean number of days during which Salmonella was recovered 
100% 
90% 
80% 
Cl) 70% 
> :,.:; ·w 60% -
0 a.. 50% c 
40% 
Cl) a.. 30% 
20% 
10% -
0% -
2 4 7 9 
Day (Challenge = 0) 
11 14 
Sterile Milk 
DGS-1 
Figure 12. Trial 6 Salmonella culture-positive tonsil samples 
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from individual tonsil samples in the GS-1 (2.25 ± 4.5) compared to the sterile milk group 
(12.75 ± 2.5). 
Salmonella isolation from tissues. The mandibular lymph nodes, lung, liver, and spleen 
were Salmonella culture-negative in all animals (Table 13). There was no significant (P > 
0.05) difference in the proportion of tissues that were Salmonella culture-positive in the GS-1 
group (35%) compared to the sterile milk group (50%). There was no significant (P > 0.05) 
Table 13. Trial 6 Salmonella isolation from tissues 
Sam pie Sterile Milk GS-1 
Tonsil 
Mandibular Lymph Node 
Lung 
Liver 
Spleen 
Jejunal Lymph Node 
Ileocecal Lymph Node 
Ileum Contents 
Cecum Contents 
Colon Contents 
Total 
(positive/total) (positive/total) 
3/4 0/4 
2/4 0/4 
0/4 0/4 
0/4 0/4 
0/4 0/4 
1/4 0/4 
3/4 3/4 
3/4 3/4 
4/4 4/4 
4/4 4/4 
20/40 (50%) 14/40 (35%) 
difference in the mean Salmonella CFU per gram of cecum contents in the GS-1 group (268 
± 195) and the sterile milk group (192 ± 221 ). Although the mean Salmonella CFU per gram 
of tonsil in the GS-1 group was zero (0 ± 0) this was not significantly (P > 0.05) different 
than sterile milk group (1318 ± 2390). 
In Vitro Experiments 
Strain identification 
Lactobacillus sp. strains GS-1 and GS-2 were tested for their ability to ferment 49 
carbohydrates using the API CHL 50 system (Table 14). Based upon carbohydrate 
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Table 14. Carboyhydrate fermentation patterns of Lactobacillus sp. GS-1 
and Lactobacillus se. GS-2 
Carbohl'.drate GS-1 GS-2 Carbohl'.drate GS-1 GS-2 
Glycerol Salicine + 
Erythritol Cellobiose + 
D-Arabinose Maltose + + 
L-Arabinose Lactose + 
Ribose + Melibiose + 
D-Xylose Saccharose + + 
L-Xylose Trehalose + 
Adonitol Inuline 
p Methyl-xyloside Melezitose 
Galactose + + D-Raffinose + 
D-Glucose + + Amidon 
D-Fructose + Glycogene 
D-Mannose + Xylitol 
L-Sorbose p Gentiobiose + 
Rhamnose D-Turanose 
Dulcitol D-Lyxose 
Inositol D-Tagatose 
Mannitol + D-Fucose 
Sorbitol + L-Fucose 
a Methyl-D-mannoside - D-Arabitol 
a Methyl-D-glucoside L-Arabitol 
N Acetyl glucosamine + Gluconate + 
Amygdaline + 2 Keto-gluconate -
Arbutine + 5 Keto-gluconate -
Esculine + + 
(+)Positive(-) Negative 
fermentation profiles, Lactobacillus sp. strain GS- I and Lactobacillus sp. strain GS-2 were 
identified as Lactobacillus paracasei subsp. paracasei and Lactobacillus fermentum, 
respectively. These strains were assigned the following names by our laboratory: L. 
paracasei subsp. paracasei GS-I and L. fermentum GS-2. 
Antibiotic resistant Lactobacillus mutants 
Colonies of Lactobacillus paracasei subsp. paracasei GS-I and Lactobacillus fermentum 
GS-2 were isolated on MRS agar containing 30 µ1/ml of rifampin and 400 µ1/ml of 
streptomycin. The isolates were identified as Lactobacillus paracasei subsp. paracasei GS-I 
(Rif /Stl) and Lactobacillus fermentum GS-2 (Rif /StrR), respectively. 
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Figure 13. Salmonella Typhimurium x4232 expressing GFP 
Salmonella Typhimurium x4232 expressing GFP 
The ability of Salmonella Typhimurium x4232 containing the p VLac plasmid to express 
GFP was confirmed by exciting colonies grown on an agar plate with a handheld darkreader 
lamp. Individual bacteria expressing GFP was confirmed by epiflourescent microscopy of a 
Figure 14. Porcine phagocytes containing Salmonella Typhimurium x4232/GFP 
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wet mount overnight culture of Salmonella Typhimurium x4232/GFP (Figure 13). 
Salmonella Typhimurium x4232/GFP in porcine phagocytes 
The ability of Salmonella Typhimurium x4232/GFP to express GFP in porcine phagocytes 
was confirmed by epiflourescent microscopy (Figure 14). Porcine phagocytes were 
identified by red-colored nuclei. Individual bacteria could be visualized within porcine 
phagocytes. 
Plasmid profiles 
Plasmid profiles of L. paracasei subsp. paracasei GS-1 and L. fermentum GS-2 are shown 
in Figure 15A. Three distinct bands (~1.2 kb, 7 kb, and ~20 kb) were resolved in the strain 
GS-1 profile while the strainGS-2 profile was not resolved (Figure 15A). Comparison of 
plasmid profiles of strains GS-1, GS-1 H, and L T-60 (Figure 15B) revealed no difference in 
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Figure 14. A. 1 kb ladder (lane 1) GS-1 (lane 2) GS-2 (lane 3) B. GS-lH (lane 1) LT-60 
(lane 2) GS-1 (lane 3) 1 kb ladder (lane 4). 
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the plasmid profiles of high and low passage isolates of strain GS-1. 
In vitro inhibition of Salmonella Typhimurium strain B by Lactobacillus species 
Lactobacillus spp. strains GS-1, GS-1 H, GS-2, L T-60, and L T-61 inhibited growth of 
Salmonella Typhimurium strain B (Figure 16). Spent media from overnight cultures of strain 
GS-1 and strain GS-2 did not inhibit Salmonella Typhimurium strain B grown in the well 
diffusion assay. Salmonella Typhimurium strain B was not inhibited by the well diffusion 
assay using 0-25%, 25-50%, 50-75% or 75-100% ammonium sulfate cuts. A pH gradient 
was associated with each zone of inhibition in Salmonella Typhimurium strain B growth. The 
pH at the edge of the zone of inhibition was ~4.4 while the pH immediately within the agar 
underlying the Salmonella Typhimurium strain B confluent growth was ~5.2. MRS broth 
adjusted to pH 3.8 and 4.2 for GS-1 and GS-2, respectively did not inhibit Salmonella 
Typhimurium strain Bin the agar well diffusion assay. 
Figure 16. Spot test of Lactobacillus species and Salmonella Typhimurium strain B 
50 
CHAPTER 5. DISCUSSION 
In Vivo Experiments 
The initial goal of these experiments was to evaluate feeding yogurt cultures as a method 
to reduce levels of Salmonella Typhimurium in pigs. Pigs were daily fed one of two 
Lactobacillus yogurt cultures prior to and after inoculation with Salmonella Typhimurium 
strain B . After the pigs were inoculated intranasally with Salmonella Typhimurium strain B, 
the presence of Salmonella was monitored from fecal samples, tonsil samples, and internal 
organs of the pigs. Also, anti-Salmonella serum antibody levels were monitored on a weekly 
basis after inoculation with Salmonella Typhimurium strain B. It was hypothesized that 
feeding yogurt cultures would be associated with increased anti-Salmonella serum antibody 
levels and decreased levels of Salmonella in the feces and tissues of pigs compare to controls. 
Trial I was designed to evaluate the anti-Salmonella serum antibody levels in pigs fed L. 
paracasei subsp. paracasei GS-I yogurt or L. fermentum GS-2 yogurt and inoculated with 
Salmonella Typhimurium strain B. On day 7, the mean anti-Salmonella serum antibody 
levels in both yogurt groups were lower than those in the sterile milk group. Interestingly, 
these serum antibody results corresponded to an unexpected decrease in the number of 
Salmonella culture-positive fecal samples that were collected from the GS-I and GS-2 
groups compared to the sterile milk group. By the end of the trial, the mean antibody levels 
in both yogurt groups remained lower than those in the sterile milk group. The trend towards 
reduced Salmonella culture-positive fecal samples in the yogurt groups also continued 
throughout the study. In addition, the mean Salmonella CFU per gram of tonsil in the GS-1 
and GS-2 groups was lower than the sterile milk group on day 27. This difference, however, 
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___ was not significant due to high variation between pigs and few degrees of freedom. While 
both yogurt-fed groups had decreased levels of Salmonella, the effect was greatest in the GS-
1 group. Consequently, the L. paracasei subsp. paracasei GS-1 yogurt culture was selected 
for further evaluation. 
Trial 2 was designed to repeat trial 1 and to examine the effect of feeding L. paracasei 
subsp. paracasei GS-1 yogurt on the Salmonella levels in tissues of pigs shortly (within 9 
days) after the pigs were inoculated with Salmonella Typhimurium strain B. Therefore, 
internal organs from pigs were collected for Salmonella isolation on days 2, 9 and 27. In trial 
1, no Salmonella culture-positive fecal samples were collected from any animal in the GS-1 
group after day 9. Thus, it was hypothesized that decreased fecal shedding would correlate 
with decreased levels of Salmonella within tissues of pigs by day 9. 
In trial 2, the results of Salmonella isolation from fecal and tonsil samples were similar to 
those in trial 1. The mean Salmonella CFU per gram of tonsil, ileocecal lymph node, and 
cecum contents were lower in the GS-1 group than sterile milk group on days 2 and 9. 
However, the difference was not significant due, in part, to the high variation between pigs 
and few degrees of freedom. 
Cumulative results from trials 1 and 2 demonstrated a model that detected differences in 
the probiotic qualities between two species of Lactobacillus. Trials 1 and 2 also showed that 
feeding L. paracasei subsp. paracasei GS-1 yogurt repeatedly reduced levels of Salmonella 
in tonsil and fecal samples of pigs 
Results from trials 1 and 2 only allow the speculation of the in vivo pro biotic mechanisms 
of L. paracasei subsp. paracasei GS-1 yogurt. In these trials, there was a dramatic decrease 
in fecal shedding of Salmonella in the GS-1 group compared to the sterile milk controls by 
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day 2. However, there was-no significant difference in the mean anti-Salmonella antibody 
levels in either group on any day. Since primary adaptive immune responses take between 4 
and 7 days to develop, these results indicate that a mechanism( s) other than the stimulation of 
an adaptive immune response may account for the reduction in Salmonella levels between 
days O and 7. Decreased pH in the gut lumen, competition for adhesion sites and nutrients, 
production of anti-microbial substances, and stimulation of non-specific or cellular immune 
responses may also be involved as mechanisms.33•66 
Trial 3 was designed to investigate the mechanism(s) for the reduction of Salmonella in 
pigs fed GS-1 yogurt. To evaluate the role of live L. paracasei subsp. paracasei GS-1 and 
heat-labile constituents in the yogurt cultures, live L. paracasei subsp. paracasei GS-1 yogurt 
cultures were killed either by irradiation or heat, respectively. The results of Salmonella 
isolation from fecal and tonsil samples in the GS-1 group and sterile milk group were unlike 
the results from trials 1 and 2. Furthermore, there was no significant difference between the 
Salmonella levels in the tonsil and fecal samples from pigs in either the irradiated or heat-
killed L. paracasei subsp. paracasei GS-1 yogurt groups compared to pigs in the live L. 
paracasei subsp. paracasei GS-1 yogurt group. 
Examination of culture records indicated that the L. paracasei subsp. paracasei GS-1 stock 
cultures used to inoculate all of the yogurt cultures for trial 3 had been sub-cultured daily in 
MRS broth for 40 days prior to the beginning of trial 3. Experimental evidence has shown 
that bacteriocins produced by lactobacilli may be plasmid-bome.49 Furthermore, plasmids 
from some Lactobacillus species are quickly cured as a result of in vitro sub-culturing. 85 
Thus, it was hypothesized that plasmid-borne bacteriocin of L. paracasei subsp. paracasei 
GS-1 may have been cured during sub-culturing. 
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Trial 4 was designed to evaluate differences between yogurt cultures of high and low 
passage isolates of L. paracasei subsp. paracasei GS-1 to reduce levels of Salmonella in 
swine. From day O through day 27, there was no significant difference in Salmonella culture-
positive fecal and tonsil samples collected from pigs in the GS-1, GS-1 H, GS-2 and sterile 
milk groups. In trials 1 through 4, antibiotic-free feed was ordered from the same feed 
source. Analyses of the feed from trials 1-3 for antibiotics were not conducted. However, 
analysis of feed from trial 4 revealed that oxytetracycline was present in the starter diet at 
~25 ppm. In vitro sensitivity assays showed that both L. paracasei subsp. paracasei GS-1 
and L. fermentum GS-2 were sensitive to oxytetracycline. Consequently, it was hypothesized 
that oxytetracycline in the trial 4 feed may have inhibited the probiotic effects of L. paracasei 
subsp. paracasei GS-1 yogurt that were observed in trials 1 and 2. 
Trial 5 was designed to repeat trial 1 using antibiotic-free feed from a different feed 
source. In addition, the effects of Lactobacillus paracasei subsp. paracasei GS-1 yogurt 
cultures supplemented with fructooligosaccharide (FOS) were evaluated. Herich et al. 
showed that the addition of FOS to a Lactobacillus paracasei pro biotic improved the 
immunostimulative effects and survival rate of the pro biotic in pigs.42 Thus it was 
hypothesized that the addition of FOS would improve the pro biotic effects of L. paracasei 
subsp. paracasei GS-1 yogurt. From day O through day 27, there was no significant 
difference in Salmonella culture-positive fecal and tonsil samples collected from pigs in the 
GS-1, GS-1 + FOS, GS-2 and sterile milk groups. 
Argus SC TM (Intervet Inc., Millsboro, DE) is an attenuated Salmonella enterica subsp. 
enterica serovar Cholerasuis vaccine that has been used to reduce shedding and tissue 
colonization of Salmonella Typhimurium in pigs. 12•37•103 In order to detect differences in 
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tissue colonization and fecal shedding between Argus SC™ vaccinates and non-vaccinated 
controls, the challenge dose of Salmonella Typhimurium had to be reduced from 108 CFU to 
106 CFU per animal. 103 The mechanism of protection by Argus sc™ probably involves an 
adaptive immune response to Salmonella Cholerasuis that provides cross-protection to 
Salmonella Typhimurium. Since yogurt treatment alone cannot induce an adaptive immune 
response to Salmonella Typhimurium, the challenge dose (108 CFU per animal) used in trials 
1-5 may have overwhelmed any protective effect of the yogurt cultures. Thus, it was 
hypothesized that a lower challenge dose, 106 CFU per animal, would be more appropriate to 
evaluate feeding L. paracasei subsp. paracasei GS-1 yogurt as a method to reduce 
Salmonella Typhimurium in pigs. 
Trial 6 was designed to evaluate feeding of L. paracasei subsp. paracasei GS-1 yogurt to 
reduce Salmonella levels in pigs challenged with 106 CFU per animal. Throughout the trial, 
results of Salmonella isolation from tonsil samples were similar to those collected in trials 1 
and 2. Until day 11, the results from fecal samples were also similar to those collected in 
trials 1 and 2. On day 14, more Salmonella culture-positive fecal samples were collected 
from the pigs in the GS-1 group than the sterile milk group. The mean number of days during 
which Salmonella was recovered from individual animals in the GS-1 group was lower than 
the sterile milk group. These results were similar to those in trials 1 and 2. Furthermore, 
Salmonella was not isolated from any of the tonsils of the pigs in the GS-1 group on day 14. 
This difference was not significant due to high variation between pigs and few degrees of 
freedom. 
Several sources of variability may have contributed to the inconsistent reduction of 
Salmonella in pigs fed Lactobacillus yogurt cultures. First, different strains of Lactobacillus 
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---- --- may have inherently different probiotic effects. Such strain-dependent variation has been 
reported in models of disease, weight gain, and immune function in chickens, mice and 
pigs.31 ,46,51 •58,73 ,79,81 •84•90,96,106-108 The results from trial 1 showed differences between L. 
paracasei subsp. paracasei GS-1 and L. fermentum GS-2 in their ability to reduce the levels 
of Salmonella Typhimurium in pigs. Both yogurt cultures were associated with a reduction 
in Salmonella levels. However, a more dramatic effect was associated with the L. paracasei 
subsp. paracasei GS-1 yogurt. 
A second possible source of variability is animal genetics. In the present studies, feeding 
GS- I yogurt cultures significantly reduced Salmonella levels in the tonsil samples in pigs 
from Farms A and C (Trials 1,2, and 6). Significant effects of feeding L. paracasei subsp. 
paracasei GS-I yogurt on Salmonella levels in fecal samples, however, were limited to the 
pigs from Farm A (Trials I and 2). Among the pigs from Farm A, the effect of feeding L. 
paracasei subsp. paracasei GS-I yogurt on Salmonella levels in fecal samples, tonsil 
samples, and internal organs was variable (Trials I through 4 ). Thus variability was 
observed between and among farms. As a result, conclusions regarding the influence of 
animal genetics in these studies are not possible. 
A third source of variation may be related to the origins of L. paracasei subsp. paracasei 
GS-I and L. fermentum GS-2. Both were isolated from the pars esophagus of normal pigs. In 
some strains of Lactobacillus, the peptidoglycan layer is associated with intrinsic adjuvant 
activity.57•76•86 Furthermore, the S-layer proteins of some Lactobacillus strains are believed 
to be involved in adhesion to epithelial cells and adjuvant activity. 87 In the pig gut, 
immunocompetent cells are present in the Peyer' s patches as a part of the GALT (gut-
associated lymphoid tissue). 74 It is possible that L. paracasei subsp. paracasei GS- I and L. 
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fermentum GS-2 are only capable of adhering to the pars esophagus but not the epithelial 
cells of the Peyer' s patches. If this is true, immune stimulation by these strains may be 
precluded by their inability to associate with Peyer's patches. 
A fourth source of variation may be related to the ecology of the gut. According to 
DuBois et al., the indigenous micro biota is made up of three parts: the autochthonous flora, 
the normal flora and pathogens. 26 Autochthonous bacteria have existed throughout the 
evolution of the host and are found in every individual within a species. Constituents of the 
normal flora may vary geographically but are present in all members of a specific 
community. Allochthonous bacteria, on the other hand, are strains that do not normally 
colonize an individual or a specific niche within an individual.93•97 Consequently, they are 
not autochthonous. However, allochthonous bacteria may be normal flora in one community 
but not another. 
If allochthonous bacteria enter the gut, they probably encounter a very harsh environment 
and are not likely to colonize or persist for long periods of time. Consequently, if 
administered orally, they may only be recovered in fecal samples for a short period of time 
after administration has ceased. Furthermore, allochthonous bacteria are "foreign" to the 
host. As a result, they may be capable of stimulating the immune response unlike 
autochthonous and normal flora to which the host has been tolerized. In mice, the immune 
system was stimulated to a greater extent in animals that were fed human isolates of 
Lactobacillus (an allochthonous strain) than in mice fed mouse isolates of Lactobacillus 
(autochthonous or normal strains).9 
In trials 1 and 2, L. paracasei subsp. paracasei GS-1 and L. fermentum GS-2 may have 
been allochthonous, relative to the pigs to which they were fed. As a result, both strains may 
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have stimulated an innate or non-humoral immune response that may have led to resistance 
to Salmonella infection. In subsequent trials, both strains may have been constituents of the 
pigs' normal flora. Consequently, the immune system may have been tolerized to these 
particular strains and was therefore not stimulated by increased numbers of these 
Lactobacillus speceis in the gut. In the future, yogurt cultures containing non-swine 
isolate(s) of Lactobacillus or other LAB would facilitate the evaluation of allochthonous vs. 
normal flora and their ability to reduce the shedding of Salmonella Typhimurium in swine. 
Furthermore, such experiments may lead to the identification of bacteria that exhibit 
consistent probiotic effects in pigs. 
In Vitro Experiments 
The goals of these experiments were to 1.) identify Lactobacillus sp. strains GS-1 and GS-
2 to the species level, 2.) characterize Lactobacillus sp. strain GS-1 and GS-2 based upon 
plasmid profiles and in vitro bactericidal activity against Salmonella Typhimurium, and 3.) 
develop markers for Salmonella and Lactobacillus species for use in in vivo studies. 
Lactobacillus sp. strain GS-1 and Lactobacillus sp. strain GS-2 were identified by the API 
50 CHL test as Lactobacillus paracasei subsp. paracasei and Lactobacillus fermentum, 
respectively. Plasmid profiles of both isolates demonstrated another method to differentiate 
both strains. The plasmid profile of L. paracasei subsp. paracasei GS-1 resolved three 
distinct bands while the profile of L. fermentum GS-2 appeared as a smear on the gel. Others 
have reported poor quality mini-preps from some strains of Lactobacillus.56 Some strains 
have outer S-layers and peptidoglycan layers that are difficult to lyse. Consequently, mini-
preps appear as a smear due to high levels of protein and carbohydrate impurities. 
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The similarity among plasmid profiles of high and low passage isolates of L. paracasei 
subsp. paracasei GS-1 indicates that the three predominant plasmids found in these isolates 
are stable during sub-culturing in MRS broth. The inherent stability of these plasmids 
suggests that they may be candidates for cloning vectors in L. paracasei subsp. paracasei 
GS-1. 
The bactericidal effect of the Lactobacillus strains against Salmonella Typhimurium strain 
B may be due to several factors. In these assays, pH 4.2 or lower in the agar was associated 
with the zone of inhibition. However, un-inoculated MRS broth controls (pH 3.7 and 4.2 for 
GS-1 and GS-2, respectively) did not inhibit the growth of Salmonella Typhimurium strain B 
in either the spot test assay or the agar well diffusion assay. 
Bacteriocins, which are biologically active peptides produced by a number of bacteria 49, 
may also contribute to the bactericidal effect observed. However, concentrated SCS of L. 
paracasei subsp. paracasei GS-1 and L. fermentum GS-2, obtained by ammonium sulfate 
precipitation, did not inhibit the growth of Salmonella Typhimurium strain B in either the 
spot test or agar well diffusion assay. Thus, the mechanisms of in vitro bactericidal effects of 
L. paracasei subsp. paracasei GS-1 and L. fermentum GS-2 remain unknown. 
Since many species of Lactobacillus are present in high numbers within the gut of animals, 
it can be difficult to differentiate an administered Lactobacillus isolate from a Lactobacillus 
isolate that is part of the animals' indigenous flora. L. paracasei subsp. paracasei GS-1 
(RifSt) and L. fermentum GS-2 (RifSt) will facilitate detection, isolation and 
enumeration of these particular strains after they have been fed to pigs. Similar strains have 
been developed and successfully used to study Lactobacillus colonization in pigs.95 
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The mechanisms of Salmonella Typhimurium dissemination through the body of pigs are 
not clearly understood. Fedorka-Cray et al. have shown that Salmonella Typhimurium can 
invade and disseminate from the nostrils to the gut and internal tissues of pigs through a 
mechanism other than the fecal-oral route.30 In mice, a similar mechanism has been reported 
that involves dissemination through CD 18-expressing phagocytes. 105 
The GFP-expressing strains of Salmonella Typhimurium x4232 developed in these studies 
will be useful in flow cytometric assays. Such assays may provide insight to the mechanisms 
of invasion of Salmonella Typhimurium in pigs. Together, the strains of Lactobacillus and 
Salmonella developed in these studies may be used to evaluate microbe-microbe interactions 
and host-microbe interactions in vivo. Results of such studies may provide a better 
understanding of the pro biotic mechanisms of lactobacilli in swine. 
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CHAPTER 6. CONCLUSIONS 
In the experiments described herein, various preparations of yogurt cultures from two 
isolates of Lactobacillus were evaluated as a method to reduce levels of Salmonella 
Typhimurium in swine. In two of six trials, feeding live Lactobacillus paracasei subsp. 
paracasei GS-1 yogurt cultures significantly reduced levels of Salmonella in tonsil and fecal 
samples from swine. These studies show species-dependent effects of orally administered 
Lactobacillus yogurt cultures on the levels of Salmonella Typhimurium in swine. The main 
conclusion of the present study is that Lactobacillus yogurt cultures can reduce levels of 
Salmonella Typhimurium in swine. While the inconsistent results currently preclude the use 
of this method in swine production, they encourage further research. 
Several factors that may influence the pro biotic effects of lactobacilli should be 
investigated. These factors include animal genetics, composition of the diet, indigenous 
flora, and the age of the animals. The bacterial strains described in these experiments will 
aid in the study of these sources of variation and will facilitate the delineation of the in vivo 
pro biotic mechanisms of lactobacilli. 
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